Trevi Therapeutics, Inc. (TRVI)

NASDAQ: TRVI · IEX Real-Time Price · USD

2.540

-0.110 (-4.15%)

At close: Apr 25, 2024, 4:00 PM

2.460

-0.080 (-3.15%)

After-hours: Apr 25, 2024, 6:49 PM EDT

Trevi Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Net Income	-29.07	-29.15	-33.94	-32.76	-26.75	-25.58	-12.54
Depreciation & Amortization	0.12	0.04	0.05	0.05	0.04	0.02	0
Share-Based Compensation	2.25	2.33	2.54	2.42	1.13	0.5	0.21
Other Operating Activities	-5.02	-1.39	2.4	1.29	1.79	1.74	4.68
Operating Cash Flow	-31.71	-28.18	-28.95	-29	-23.09	-18.29	-7.98
Capital Expenditures	-0.14	-0.16	0	-0.03	-0.01	-0.16	-0.01
Change in Investments	59.57	-107.21	0	0	0	0	0
Investing Cash Flow	59.43	-107.37	0	-0.03	-0.01	-0.16	-0.01
Share Issuance / Repurchase	1.85	117.39	21.23	3.18	65.14	-1.52	0.06
Debt Issued / Paid	-9.5	-5.85	-0.07	13.92	-0.68	-5.35	-8.26
Other Financing Activities	-0.26	-0.23	-0.38	-0.38	8.75	10.5	29.92
Financing Cash Flow	-7.91	111.31	20.78	16.72	73.21	3.63	21.72
Net Cash Flow	19.81	-24.24	-8.17	-12.31	50.11	-14.82	13.73
Free Cash Flow	-31.85	-28.33	-28.95	-29.03	-23.1	-18.45	-7.99
Free Cash Flow Per Share	-0.32	-0.44	-1.27	-1.61	-1.97	-42.15	-18.99

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).